Search Page

1

Cite

Share

The immunocytokine NHS-IL12 as a potential cancer therapeutic.

Fallon J, Tighe R, Kradjian G, Guzman W, Bernhardt A, Neuteboom B, Lan Y, Sabzevari H, Schlom J, Greiner JW. Fallon J, et al. Among authors: sabzevari h. Oncotarget. 2014 Apr 15;5(7):1869-84. doi: 10.18632/oncotarget.1853. Oncotarget. 2014. PMID: 24681847 Free PMC article.

Cite

Share

2

Cite

Share

Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β.

Lan Y, Zhang D, Xu C, Hance KW, Marelli B, Qi J, Yu H, Qin G, Sircar A, Hernández VM, Jenkins MH, Fontana RE, Deshpande A, Locke G, Sabzevari H, Radvanyi L, Lo KM. Lan Y, et al. Among authors: sabzevari h. Sci Transl Med. 2018 Jan 17;10(424):eaan5488. doi: 10.1126/scitranslmed.aan5488. Sci Transl Med. 2018. PMID: 29343622

Cite

Share

3

Cite

Share

Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009.

Pellom ST, Smalley Rumfield C, Morillon YM 2nd, Roller N, Poppe LK, Brough DE, Sabzevari H, Schlom J, Jochems C. Pellom ST, et al. Among authors: sabzevari h. JCI Insight. 2021 Apr 8;6(7):e141912. doi: 10.1172/jci.insight.141912. JCI Insight. 2021. PMID: 33651712 Free PMC article.

Cite

Share

4

Cite

Share

Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis.

Lee MY, Metenou S, Brough DE, Sabzevari H, Bai K, Jochems C, Schlom J, Allen CT. Lee MY, et al. Among authors: sabzevari h. NPJ Vaccines. 2021 Jun 18;6(1):86. doi: 10.1038/s41541-021-00348-x. NPJ Vaccines. 2021. PMID: 34145272 Free PMC article.

Cite

Share

5

Cite

Share

Costimulatory molecules as adjuvants for immunotherapy.

Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J. Hodge JW, et al. Among authors: sabzevari h. Front Biosci. 2006 Jan 1;11:788-803. doi: 10.2741/1837. Front Biosci. 2006. PMID: 16146771 Review.

Cite

Share

6

Cite

Share

Similarities and differences between helminth parasites and cancer cell lines in shaping human monocytes: Insights into parallel mechanisms of immune evasion.

Narasimhan PB, Akabas L, Tariq S, Huda N, Bennuru S, Sabzevari H, Hofmeister R, Nutman TB, Tolouei Semnani R. Narasimhan PB, et al. Among authors: sabzevari h. PLoS Negl Trop Dis. 2018 Apr 18;12(4):e0006404. doi: 10.1371/journal.pntd.0006404. eCollection 2018 Apr. PLoS Negl Trop Dis. 2018. PMID: 29668679 Free PMC article.

Cite

Share

7

Cite

Share

Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor.

Vandeveer AJ, Fallon JK, Tighe R, Sabzevari H, Schlom J, Greiner JW. Vandeveer AJ, et al. Among authors: sabzevari h. Cancer Immunol Res. 2016 May;4(5):452-62. doi: 10.1158/2326-6066.CIR-15-0176. Epub 2016 Feb 26. Cancer Immunol Res. 2016. PMID: 26921031 Free PMC article.

Cite

Share

8

Cite

Share

Distinct effects of saracatinib on memory CD8+ T cell differentiation.

Takai S, Sabzevari H, Farsaci B, Schlom J, Greiner JW. Takai S, et al. Among authors: sabzevari h. J Immunol. 2012 May 1;188(9):4323-33. doi: 10.4049/jimmunol.1101439. Epub 2012 Mar 26. J Immunol. 2012. PMID: 22450814 Free PMC article.

Cite

Share

9

Cite

Share

Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer.

Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL. Hu P, et al. Among authors: sabzevari h. Clin Cancer Res. 2008 Jan 15;14(2):579-88. doi: 10.1158/1078-0432.CCR-07-0940. Clin Cancer Res. 2008. PMID: 18223234

Cite

Share

10

Cite

Share

Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells.

Lutsiak ME, Tagaya Y, Adams AJ, Schlom J, Sabzevari H. Lutsiak ME, et al. Among authors: sabzevari h. J Immunol. 2008 May 1;180(9):5871-81. doi: 10.4049/jimmunol.180.9.5871. J Immunol. 2008. PMID: 18424706 Free PMC article.

Cite

Share